Guidelines for the treatment of acute ischaemic stroke
- PMID: 22152803
- DOI: 10.1016/j.nrl.2011.09.012
Guidelines for the treatment of acute ischaemic stroke
Abstract
Introduction: Update of Acute Ischaemic Stroke Treatment Guidelines of the Spanish Neurological Society based on a critical review of the literature. Recommendations are made based on levels of evidence from published data and studies.
Development: Organized systems of care should be implemented to ensure access to the optimal management of all acute stroke patients in stroke units. Standard of care should include treatment of blood pressure (should only be treated if values are over 185/105 mmHg), treatment of hyperglycaemia over 155 mg/dl, and treatment of body temperature with antipyretic drugs if it rises above 37.5 °C. Neurological and systemic complications must be prevented and promptly treated. Decompressive hemicraniectomy should be considered in cases of malignant cerebral oedema. Intravenous thrombolysis with rtPA should be administered within 4.5 hours from symptom onset, except when there are contraindications. Intra-arterial pharmacological thrombolysis can be considered within 6 hours, and mechanical thrombectomy within 8 hours from onset, for anterior circulation strokes, while a wider window of opportunity up to 12-24 hours is feasible for posterior strokes. There is not enough evidence to recommend routine use of the so called neuroprotective drugs. Anticoagulation should be administered to patients with cerebral vein thrombosis. Rehabilitation should be started as early as possible.
Conclusion: Treatment of acute ischaemic stroke includes management of patients in stroke units. Systemic thrombolysis should be considered within 4.5 hours from symptom onset. Intra-arterial approaches with a wider window of opportunity can be an option in certain cases. Protective and restorative therapies are being investigated.
Keywords: Brain protection; Cerebral infarct; Cerebral venous thrombosis; Cerebroprotección; Ictus isquémico; Infarto cerebral; Ischaemic stroke; Stroke units; Thrombolysis; Trombosis venosa cerebral; Trombólisis; Unidades de ictus.
Copyright © 2011 Sociedad Española de Neurología. Published by Elsevier Espana. All rights reserved.
Comment in
-
Remarks on cerebral infarct from another point of view.Neurologia. 2016 Mar;31(2):134-5. doi: 10.1016/j.nrl.2014.04.003. Epub 2014 May 16. Neurologia. 2016. PMID: 24837335 English, Spanish. No abstract available.
-
Reply to letter "Remarks on cerebral infarct from another point of view".Neurologia. 2016 Mar;31(2):136. doi: 10.1016/j.nrl.2014.06.001. Epub 2014 Jul 23. Neurologia. 2016. PMID: 25064157 English, Spanish. No abstract available.
Similar articles
-
[Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].Rev Neurol (Paris). 2012 Jun;168(6-7):512-21. doi: 10.1016/j.neurol.2012.01.587. Epub 2012 May 28. Rev Neurol (Paris). 2012. PMID: 22647807 Review. French.
-
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17. Stroke. 2003. PMID: 12869717
-
An update on hyper-acute management of ischaemic stroke.Clin Med (Lond). 2021 May;21(3):215-221. doi: 10.7861/clinmed.2020-0998. Epub 2021 May 4. Clin Med (Lond). 2021. PMID: 33947658 Free PMC article. Review.
-
[New options in the therapeutic management of acute ischaemic stroke. Good results with combined i. v. and i. a. lysis and mechanical thrombectomy].Fortschr Neurol Psychiatr. 2010 Nov;78(11):652-7. doi: 10.1055/s-0029-1245582. Epub 2010 Nov 10. Fortschr Neurol Psychiatr. 2010. PMID: 21069630 German.
-
Intervention in acute cerebral ischaemic stroke: a review of the role of pharmacological therapies and intra-arterial mechanical thrombectomy devices.Postgrad Med J. 2011 Oct;87(1032):714-23. doi: 10.1136/pgmj.2010.105171. Epub 2011 Jul 23. Postgrad Med J. 2011. PMID: 21785159 Review.
Cited by
-
Single-Nucleotide Polymorphism 309T>G in the MDM2 Promoter Determines Functional Outcome After Stroke.Stroke. 2018 Oct;49(10):2437-2444. doi: 10.1161/STROKEAHA.118.022529. Stroke. 2018. PMID: 30355102 Free PMC article.
-
Frequency, Risk Factors, and Prognosis of Dehydration in Acute Stroke.Front Neurol. 2019 Mar 29;10:305. doi: 10.3389/fneur.2019.00305. eCollection 2019. Front Neurol. 2019. PMID: 30984104 Free PMC article.
-
[Electroacupuncture pretreatment alleviates cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through the gut-brain axis and the Nrf2/HO-1 signaling pathway].Nan Fang Yi Ke Da Xue Xue Bao. 2025 May 20;45(5):911-920. doi: 10.12122/j.issn.1673-4254.2025.05.03. Nan Fang Yi Ke Da Xue Xue Bao. 2025. PMID: 40415422 Free PMC article. Chinese.
-
Potential Mechanism and Perspectives of Mesenchymal Stem Cell Therapy for Ischemic Stroke: A Review.Glob Med Genet. 2024 Sep 2;11(4):278-284. doi: 10.1055/s-0044-1790231. eCollection 2024 Dec. Glob Med Genet. 2024. PMID: 39224463 Free PMC article. Review.
-
The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism.Transl Stroke Res. 2019 Apr;10(2):204-215. doi: 10.1007/s12975-018-0631-1. Epub 2018 Apr 23. Transl Stroke Res. 2019. PMID: 29687302 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical